A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Clinical trial NCT02423902 · TERMINATED
Trial details
- NCT number
- NCT02423902
- Sponsor
- Alaunos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-18
- Primary completion
- 2016-07-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.